(Q36334874)

13 August 2017

1 reference

title

Peripheral gammadelta T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma (English)

1 reference

13 August 2017

1 reference

3

Bernard Escudier

1 reference

13 August 2017

Emilie Viey

1

1 reference

13 August 2017

Catherine Laplace

series ordinal

2

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Expert Review of Anticancer Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

973-986

1 reference

Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Lymphadenectomy for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

The genetic basis of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Spontaneous regression of metastases of renal cancer: A report of two cases including the first recorded regression following irradiation of a dominant metastasis and review of the world literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Patterns of Human Tumor-Infiltrating Lymphocytes in 120 Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Lymphotoxin-mediated regulation of gammadelta cell differentiation by alphabeta T cell progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Prominence of gamma delta T cells in the ruminant immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Human V gamma 2V delta 2 T cells produce IFN-gamma and TNF-alpha with an on/off/on cycling pattern in response to live bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Implication of gammadelta T cells in the human immune response to cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Escherichia coli produces phosphoantigens activating human gamma delta T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Structure of a human gammadelta T-cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

V delta 2+ gamma delta T lymphocytes are cytotoxic to the MCF 7 breast carcinoma cell line and can be detected among the T cells that infiltrate breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Killing of laminin receptor-positive human lung cancers by tumor infiltrating lymphocytes bearing gammadelta(+) t-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

A simple method for the propagation and purification of gamma delta T cells from the peripheral blood of glioblastoma patients using solid-phase anti-CD3 antibody and soluble IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Gammadelta T cells for immune therapy of patients with lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.973

21 January 2018

Identifiers

DOI

10.1586/14737140.5.6.973

1 reference

13 August 2017

1 reference